🤖 AI Summary
Traditional hybrid experimental designs struggle to robustly control the frequentist operating characteristics of Bayesian decisions under model misspecification and lack efficient sample size determination methods applicable to generalized posteriors. This work proposes a computationally efficient experimental design framework that requires simulations at only two sample sizes and leverages extrapolation modeling of posterior summary functions to infer performance across the entire sample size space. This approach enables identification of the minimal sample size and decision rule satisfying desired operating characteristics. It represents the first general and scalable method for sample size planning under generalized posteriors, substantially reducing computational burden while enhancing robustness to model misspecification. The method’s validity and broad applicability within Bayesian M-estimation–type experiments are demonstrated through the redesign of an adaptive clinical trial with time-to-event outcomes.
📝 Abstract
The hybrid approach to experimental design aims to control frequentist operating characteristics of Bayesian decision procedures. These operating characteristics are assessed by simulating sampling distributions of posterior summaries under assumed data-generation processes that also define posterior distributions. Model misspecification can distort effect estimation and compromise control over operating characteristics. Generalized posterior distributions are defined using generalized likelihoods that characterize data generation under fewer assumptions, enhancing the robustness of Bayesian analysis and study design. However, widely applicable and computationally efficient design methodology with generalized posteriors is lacking. We propose an economical method to determine suitable sample sizes and decision criteria associated with generalized posteriors under the hybrid approach. Using theoretical results to model posterior summaries as functions of the sample size, we efficiently assess operating characteristics throughout the sample size space given simulations conducted at only two sample sizes. While the benefits of the proposed methodology are emphasized by redesigning an adaptive clinical trial with time-to-event outcomes, we overview our framework's broader applicability to experiments involving Bayesian analogues to M-estimation.